Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Capturing epidermal stemness for regenerative medicine.
Barrandon Y, Grasset N, Zaffalon A, Gorostidi F, Claudinot S, Droz-Georget SL, Nanba D, Rochat A. Barrandon Y, et al. Among authors: zaffalon a. Semin Cell Dev Biol. 2012 Oct;23(8):937-44. doi: 10.1016/j.semcdb.2012.09.011. Epub 2012 Oct 2. Semin Cell Dev Biol. 2012. PMID: 23036530 Review.
A single epidermal stem cell strategy for safe ex vivo gene therapy.
Droz-Georget Lathion S, Rochat A, Knott G, Recchia A, Martinet D, Benmohammed S, Grasset N, Zaffalon A, Besuchet Schmutz N, Savioz-Dayer E, Beckmann JS, Rougemont J, Mavilio F, Barrandon Y. Droz-Georget Lathion S, et al. Among authors: zaffalon a. EMBO Mol Med. 2015 Apr;7(4):380-93. doi: 10.15252/emmm.201404353. EMBO Mol Med. 2015. PMID: 25724200 Free PMC article.
LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis.
Nakamura T, Hamuro J, Takaishi M, Simmons S, Maruyama K, Zaffalon A, Bentley AJ, Kawasaki S, Nagata-Takaoka M, Fullwood NJ, Itami S, Sano S, Ishii M, Barrandon Y, Kinoshita S. Nakamura T, et al. Among authors: zaffalon a. J Clin Invest. 2014 Jan;124(1):385-97. doi: 10.1172/JCI71488. Epub 2013 Dec 9. J Clin Invest. 2014. PMID: 24316976 Free PMC article.
Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis.
Campbell KN, Pennese N, Zaffalon A, Magalhaes B, Faiella M, Caster DJ, Radhakrishnan J, Tesar V, Trachtman H. Campbell KN, et al. Among authors: zaffalon a. Kidney Med. 2022 Mar 24;4(5):100457. doi: 10.1016/j.xkme.2022.100457. eCollection 2022 May. Kidney Med. 2022. PMID: 35518835 Free PMC article.